搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
6 小时
on MSN
New review suggests evaluating Tibetan medicinal herb as potential treatment for mild ...
Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well-known for its extensive therapeutic ...
17 小时
on MSN
UW Health Alzheimer’s Disease study looks to get the right treatment plans, sooner
Health Alzheimer's Disease study plans to study 2,000 volunteers' brain scans and blood work to identify biomarkers of ...
1 天
on MSN
Walk to End Alzheimer’s supports fight for a cure
Nearly one thousand people attended the Lexington Walk to End Alzheimer's in support of finding a cure for the disease.
Medical News Today
5 天
Could a once-daily pill for seizures also treat Alzheimer's disease?
A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...
News Medical on MSN
7 天
Emory researchers receive grant to explore early treatment options for Alzheimer’s disease
Emory wins $8.3 million grant from the National Institutes for Health that will support a project that aims to develop novel ...
ScienceAlert on MSN
5 天
Alzheimer's Disease Harms The Brain in 2 Distinct Phases, Study Reveals
An analysis of the genetic activity of brain cells in individuals who have died with Alzheimer's disease has revealed the ...
MassDevice
6 天
Cognito Therapeutics has positive data for Alzheimer’s-modifying therapy
Cognito Therapeutics today announced a publication demonstrating structural brain preservation with its Spectris treatment.
TMCnet
4 天
Neurophet to host Symposium featuring renowned expert in Alzheimer's disease treatment from ...
Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting ...
2 小时
Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024
MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...
AlphaGalileo
13 天
Thirty Years of Alzheimer's Disease Research: Preventive Strategies Hold Promise for Risk ...
For more than 30 years, researchers have identified and quantified genetic and lifestyle factors for Alzheimer's Disease ...
6 小时
Lexeo Therapeutics to Present New Interim Data from Phase 1/2 Trial of LX1001 at the ...
Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈